chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Rash on body. First sign showed up 8+ hours since jab on inner left arm (same arm as jab) it was splotchy and not too bothersome. The next day it had turned red and itchy. By the evening of the next day it had grown down the arm and the right arm also had measles type bumps all up and down the inner arm. Very itchy. Next it appeared on the neck and ears. By day 3 it was very very itchy and oozing small blisters/ very tiny. The 4th day it has more spots on the stomach and legs and hands. Now eyes are puffy and right eye lid is swollen. rash spot appeared to the right of right eye. Rash spots showing on right cheek. Neck rash now has a swollen bulge look. Left inner elbow and upper arm is also swollen and bulging. Everything is VERY itchy and irritating, the ears are really red and swollen at the point where the lower ear skin meets the cartilage. Some tiny blisters continue to ooze and everything is red.
Cold, clammy, fast HR rate of 143, just didn't feel well could find words to describe it and shaky.  Left hand numbness opposite site of injection site. Set to ED to be evaluated
Patient received shot on Tuesday 9/8/20, by Friday 9/11/20 he had developed rash and some red spots/blisters. Went to Dr on Wednesday 9/16/20 and dr prescribed Medrol dose pack along with bendadryl. He said we has itchy
High fever for 3 days (103 F), nausea, vomiting, muscle ache severe headache, weakness. 2 months later the blood test showed decreased platelets by 50 % - from 300,000 to 143,000
Extremely fatigued; Stiffness; This is a spontaneous report received from a contactable other healthcare professional. A 22-years-old female patient received unknown dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: Unknown), via an unspecified route of administration, on an unspecified date as dose number unknown, single for COVID-19 immunisation and patient also received co-suspect as tofacitinib citrate (XELJANZ) (Batch/Lot number: Unknown), via an unspecified route of administration from 13Mar2021 to an unspecified date, at 5 mg for an unspecified indication. The patient medical history and concomitant medications were not reported. The patient experienced extremely fatigued on an unspecified date. Reported missing doses after receiving COVID 19 vaccine because she was extremely fatigued. on an unspecified date 2021, also had a flare up that caused stiffness throughout body that lasted the weekend and resolved on its own. The outcome of the event stiffness was reported as recovered on an unspecified date 2021 and fatigue was unknown.  No follow-up attempts are needed, information about lot/batch number cannot be obtained.
Patient came in for her initial dose in the primary series. The paperwork was correctly but in, however, the CDC vaccine card as well as the documentation on both say that the vaccine given was the bivalent pfizer vaccine instead of the monovalent novovax vaccine.
PATIENT RECEIVED VACCINE THAT EXPERIENCED A TEMPERATURE EXCURSION, VACCINE WAS KEPT IN THE REFRIGERATOR FOR MORE THAN 30 DAYS. PATIENT DID NOT HAVE ANY ADVERSE REACTIONS
1. Non-anaphylactic allergy (itchy throat, swollen lymph nodes, generalized swelling (couldn't take ring off))...about 15 mins after shot...took Benedryl 2. Severe headache...about 25 mins after shot...lasted almost exactly 24 hours...took tylenol 3. Injection site/arm pain...also lasted about 24 hours
Swelling at left upper arm injection site approx. 5cm  Itch and slightly sore for three days.  Now swelling is going down.
This is a spontaneous report from a contactable physician via a Pfizer sales representative. The physician reported 3 reports for different patients. This is the 2nd of 3 reports. An 18-year-old female patient of an unspecified ethnicity received TRUMENBA (Lot M68769, Expiration date 30Apr2017), intramuscular in left deltoid, on 22Aug2016 6:45 pm, at 0.5ml single, for immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced fever, chills, irritability, headaches, sore throat, body aches and soreness at injection site on unknown date, and streptococcal pharyngitis on 24Aug2016. Streptococcal pharyngitis was treated with ZITHROMAX for 5 days. The events were considered non serious. Laboratory data included body temperature 102 at unknown date and 99.3 on 24Aug2016. Physical examination on unknown date included positive erythema posterior pharynx, rapid strep positive, no swelling or redness at injection site. Outcome of the events was unknown. Follow-up (16Sep2016): New information received from a contactable physician includes: vaccine lot number and expiration date, additional events (sore throat, body aches and soreness at injection site), seriousness of the events (non-serious), laboratory data. Sender's Comments: Linked Report(s) : US-PFIZER INC-2016402384 Same reporter/drug/event, different patient; US-PFIZER INC-2016402459 Same reporter/drug/event, different patient.
I have a fever of 101.5; This spontaneous case was reported by a pharmacist and describes the occurrence of PYREXIA (I have a fever of 101.5) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.No Medical History information was reported.On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (I have a fever of 101.5). At the time of the report, PYREXIA (I have a fever of 101.5) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available):On an unknown date, Body temperature: 101.5 (High) High.The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.Concomitant drugs were not reported. Treatment medications were not provided.
Red spot where shot was given; Red spot at shoulder; Warm; Painful spot; Arm hurts off and on; Shoulder painful; This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 17th October 2022, the patient received the 1st dose of Shingrix (intramuscular). In October 2022, less than a week after receiving Shingrix, the patient experienced injection site erythema, erythema, skin warm, pain, pain in arm and shoulder pain. On an unknown date, the outcome of the injection site erythema, erythema, skin warm and pain were recovering/resolving and the outcome of the pain in arm and shoulder pain were not recovered/not resolved.   It was unknown if the reporter considered the injection site erythema, erythema, skin warm, pain, pain in arm and shoulder pain to be related to Shingrix.     Additional Information: GSK Receipt Date: 22-Oct-2022 and 24-Oct-2022 Reporter's comment: The patient received first dose of Shingrix on left deltoid The patient had a red spot where the shot was given (in the deltoid) and a red spot an inch above (at the shoulder) that were painful and warm. The patient's spots were finally starting to lighten up and arm only hurts off and on. The patient also experienced shoulder sore and painful. The patient was not having decreased mobility of the injected arm. The patient did not have the lot number however that information should be on record at vaccine administered at pharmacy. The reporter gave Medical doctor contact to contact her primary care physician.
prolonged crying Thursday noc;didn't cry 1st noc-(no trembling, shaking, no fever);called MD & spoke on phone Thursday 22APR;cried 10Pm-12 again 5-7AM;cried 9-10AM 23APR;22APR 103Am;
At 11:27 AM, Pt states that within approximately 10 minutes of receiving Pfizer vaccine pt c/o tingling ?to  roof of her mouth?. She notified  RN of symptoms and nurse asked her to open her mouth and observed that tongue was WNL without swelling, speech clear, no respiratory distress. Discussed with Pharmacist and instructed pt to wait another 15 min and to sit close to nurse for observation. RN  also asked pt to notify her of any worsening of symptoms and also to not leave site without evaluation of nurse. At 11:42 AM pt stated symptoms were worsening and c/o think tongue, numbness, tingling of lips. Denies any SOB or difficulty breathing.  Lungs clear to auscultation posteriorly all lobes.B/P 180/110, Left arm,  Pulse ? 100. Pt also c/o blurred vision, numbness across forehead, chest pain and pressure, dizziness and increased tiredness, denies headache and anxiousness.  At 11:46 AM 12.5mg liquid Benadryl given p.o. and after consulting with Pharmacist, another 12.5mg Benadryl given at 11:51AM and pt taken to ED via wheelchair. Pt verbalized consent.
trouble swallowing, throat closing sensation. given epi 0.3mg IM, benadryl 25mg, pepcid 20mg, prednisone 60mg. symptoms resolved.
This 87 year old male hospice received the Covid shot on  2/16/21  and died on 5/4/21.
Felt wheezy; Arm hurt; Big knot at the site of injection that is the size of ping pong/ Noticed the knot; Site of injection feels hot to touch; Worried; Red patch at the site of injection that is 2by2 inches/ patch after she received the vaccine; Injection site burns; She will not be getting the 2nd dose of the vaccine; It was much bigger; Throwing up; Under her ribs in her stomach area she felt nauseous/Really nauseous; This spontaneous case was reported by a consumer and describes the occurrence of WHEEZING (Felt wheezy), PAIN IN EXTREMITY (Arm hurt), VACCINATION SITE NODULE (Big knot at the site of injection that is the size of ping pong/ Noticed the knot), VACCINATION SITE WARMTH (Site of injection feels hot to touch) and CONDITION AGGRAVATED (It was much bigger) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jul-2021, the patient experienced NAUSEA (Under her ribs in her stomach area she felt nauseous/Really nauseous). On 31-Jul-2021, the patient experienced VOMITING (Throwing up). On 08-Aug-2021, the patient experienced CONDITION AGGRAVATED (It was much bigger). On an unknown date, the patient experienced WHEEZING (Felt wheezy), PAIN IN EXTREMITY (Arm hurt), VACCINATION SITE NODULE (Big knot at the site of injection that is the size of ping pong/ Noticed the knot), VACCINATION SITE WARMTH (Site of injection feels hot to touch), ANXIETY (Worried), VACCINATION SITE ERYTHEMA (Red patch at the site of injection that is 2by2 inches/ patch after she received the vaccine), VACCINATION SITE PAIN (Injection site burns) and PRODUCT DOSE OMISSION ISSUE (She will not be getting the 2nd dose of the vaccine). The patient was treated with PREDNISOLONE at a dose of 1 dosage form. At the time of the report, WHEEZING (Felt wheezy), PAIN IN EXTREMITY (Arm hurt), VACCINATION SITE NODULE (Big knot at the site of injection that is the size of ping pong/ Noticed the knot), VACCINATION SITE WARMTH (Site of injection feels hot to touch), CONDITION AGGRAVATED (It was much bigger), ANXIETY (Worried), NAUSEA (Under her ribs in her stomach area she felt nauseous/Really nauseous), VOMITING (Throwing up), VACCINATION SITE ERYTHEMA (Red patch at the site of injection that is 2by2 inches/ patch after she received the vaccine) and VACCINATION SITE PAIN (Injection site burns) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (She will not be getting the 2nd dose of the vaccine) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.       The patient stated that she would not receive second dose of vaccine.  Concomitant medication was not provided.
Pt states she developed a severe headache about 8PM on day she received flu shot. Continued throughout weekend- denies other sx-H/A resolving also c/o fatigue which is resolving.
This is a spontaneous report obtained from a contactable consumer (patient). A 72 year-old female patient received, on 12Oct2017 at 14:30, PREVNAR 13 in the right upper arm, at single dose, for immunization. Relevant medical history and concomitant medications were unknown. The patient reported that she did not experience any reaction in the past after her flu shot (that received every year) and after her first pneumonia shot (received 5 or 6 years before this report). It was confirmed that the patient received pneumococcal 13-val conj vac (dipht crm197 protein) on 12Oct2017 and that first day it was fine. But the next day she had some swelling and a few days after that she had worse swelling and itching. The patient experienced also redness at the injection site (about the size of a silver dollar) which spread from her shoulder to her elbow to cover her entire upper arm. It was also very warm to the touch. The patient was recovering from vaccination site swelling and vaccination site pruritus (her swelling and itchiness was a little less at time of this report). The patient did not recover from redness (at the injection site which spread from her shoulder to her elbow); while clinical outcome of vaccination site warmth was unknown.
Much heavier more painful period with palm sized blood clot; Much heavier more painful period with palm sized blood clot; Much heavier more painful period with palm sized blood clot; 2nd dose: Fatigue for 24 hours; This is a spontaneous report received from a contactable consumer (patient) or other non-health care professional.   A 45-years-old female patient (non-pregnant) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot/Batch number: EPV0150, Expiration date: unknown), via an unspecified route of administration, administered in Arm Left on 10Apr2021 10:00 as 2nd dose, single  for covid-19 immunisation. Medical history included, Hashimoto hypothyroid (from an unknown date and unknown if ongoing). Concomitant medications included levothyroxine sodium, bupropion, amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) taken for an unspecified indication, start and stop date were not reported. Patient had no known allergies. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot/Batch number: EN6207), via an unspecified route of administration, administered in Arm Left on 15Mar2020 at 17:00 PM (at the age of 45-yesr-old) first dose, single for covid-19 immunisation and experienced Migraine headache with scintillating scotoma after 12 hours fatigue for one week much heavier more painful period. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, was the patient did not diagnosed with COVID-19. Since the vaccination, patient did not tested for COVID-19. Facility where the most recent COVID-19 vaccine was administered: Doctor office/urgent care. The patient experienced after 2nd Dose fatigue for 24 hours, On Apr2021 and much heavier more painful period with palm sized blood clot, On unknown date. No treatment was received for the events. The outcome of the event fatigue was reported as recovered on Apr2021 and while for others was recovered on unknown date.   Information on Lot/Batch number was available. Additional information has been requested.
Second dose was on day 40; allergies and asthma flare up; allergies and asthma flare up; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose was on day 40), HYPERSENSITIVITY (allergies and asthma flare up) and ASTHMA (allergies and asthma flare up) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022c21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ALBUTEROL [SALBUTAMOL] for an unknown indication.    On 21-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose was on day 40), HYPERSENSITIVITY (allergies and asthma flare up) and ASTHMA (allergies and asthma flare up). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose was on day 40), HYPERSENSITIVITY (allergies and asthma flare up) and ASTHMA (allergies and asthma flare up) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-162670 (Patient Link).
The first 2 days I felt light headed, the same symptoms as if  I had a concussion.  There was also loud ringing in my left ear, which  was painful and seemed infected. I used Seagate olive leaf nasal spray and teatree oil in a diffuser for 3 days. It was gone in 3 days.   Next I experienced pain and partial numbness in the  in two toes of my right foot, and near the base of the toes. This has gotten better but still hurts and feels numb in areas.  It's interesting that aprox. 15 years ago, I went to see a doctor about the same issue persisted.  The pain was from wearing shoes that were too tight on one side. I only wore them once. The doctor said she's seen many cases like this. After several years the issue resolved on it's own.  The worst side effects are:  1.  Asthma like symptoms which make it hard to breathe.  I have taken a covid test and tested negative. I've also been isolating and wearing 2 masks including a KN95 mask.   2. Pain in my chest, especially left side.  This is gone now but lasted 2 weeks.
After immunization, patient complained of pain going down arm and back of right side of neck. Patient did not call until the next day Saturday, April 27th @ 12:14 pm. She is going to take Tylenol and Ibuprofen for the pain, as well as ice and massage area of concern. If pain worsens or does not get better- recommended to follow up with PCP.
in 24 hrs warm, swollen @ 48 hrs 4-5cm red, warm area @ site w/hard knot size of nickle, whole arm swelled up but no lymp adenopathy-started resolving in 72 hrs but didn't resolved completely for 1 wk; sx were worst between 48-72 hrs;
Patient states that he experiencing ting red rashes all along the torso, chest, and legs. Pt states it began the day after shot.
No adverse event occured, but I was 5 weeks pregnant at the time of the second vaccine and miscarried at 9 weeks.
tiredness; headache; muscle pain; fever; nausea; chills; feeling unwell; This is a spontaneous report from a contactable consumer (patient). This non-pregnant 70-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number unknown) via an unspecified route of administration in the left arm on 10Apr2021 at 10:00 (at the age of 70-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy from an unknown date and unknown if ongoing. Prior to vaccination the patient had not been diagnosed with COVID-19 and had not received any other vaccines in the four weeks prior to the COVID vaccine. Concomitant medications included sertraline hydrochloride from an unknown date for an unknown indication. On 10Apr2021 at 22:00 the patient experienced tiredness, headache, muscle pain, fever, nausea, chills, and feeling unwell. The patient reported she was unable to get out of bed for 24 hours and seated. No treatment was received for the events. The clinical outcomes of tiredness, headache, muscle pain, fever, nausea, chills, and feeling unwell were recovering. It was also reported that since vaccination the patient had not been tested for COVID-19.   No follow-up attempts are needed. No further information is expected.
Patient has had a sore/weak arm since vaccine.  Does not want to go to the doctor.
After receiving FLUZONE HD and PNEUMOVAX 23 shot on same day, same arm, patient had inject site swelling, redness, heat, ear pain in same side, flu like symptoms for 3 days.
allergic reaction; This case was reported by a consumer via interactive digital media and described the occurrence of allergic reaction in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced allergic reaction. On an unknown date, the outcome of the allergic reaction was unknown.   It was unknown if the reporter considered the allergic reaction to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient for himself/herself. The age at vaccination was not reported. The age group was not reported but was captured as an adult as per vaccine indication.  The patient had an allergic reaction to the shingles vaccine.
There is a possibility Patient may have received 0.25 ml of vaccine rather than the recommended 0.2 ml. of the Moderna Bivalent presentation for 6 months to 5 years. A staff member was not aware of the correct dosing of the bivalent vaccine. The system in place for drawing up vaccine and administering vaccine may have allowed for staff member to have drawn up 0.25 ml and another staff member to give the vaccine. It cannot be determined if the correct or incorrect amount was drawn up or given. There has been no reported adverse reaction from the parents to date.
My son was given the inactive vaccine and within 10 minutes his arm had red patches, swelling, and a fair amount of discomfort. This patches and swelling continued to spread up his arm. Since we were still in the clinic, we went back to the administering nurse. We then saw the doctor, who then put a prescription for Benadryl in the computer. We walked to the pharmacy (onsite) and were helped right away (per the doctor's orders), and administered the Benadryl. Within an hour or two, the adverse reaction disappeared. Time of vaccination is actual appointment time, so the time the vaccination was administered was probably closer to 10:30.
Very raw throat with burning, difficulty breathing but no mucus, not productive.  TONS of nasal and sinus drainage.  Light fever, light aches.  Difficulty sleeping.  Called DR who took notes and prescribed albuteral type inhaler and Prednisone.
COVID breakthrough case, tested positive on 06/18/2022. I received my 2nd booster shot on 04/29/2022 and my COVID symptoms started on 06/17/2022 breathing, sneezing, headache, no fever. I am going to the doctor tomorrow 06/27/2022.
Acute hypoxemic respiratory failure due to COVID-19; shortness of breath; elevated troponin; lactic acidosis
beginning at 8pm  day of injection (about 7 hours post injection, Wednesday January 27, 2021) axillary pain and swelling  to left arm (arm of injection) and body aches began and lasted for approximately 36 hours. about 27 hours into body aches fever to 101.5 noted.  all resolved by Saturday January 30, 2021
Vaccination 11/16/2000. Symptoms on set sudden about 30 minutes after on 11/17/2000. Sore throat, dry cough, chills runny nose. On 11/20/2000 Both knee joints. Medication Tylenol, Robatussin cough, nose spray and Augmentin
At around 11:00 pm, almost exactly 12 hours after the vaccines (Dtap & Polio) were administered, my daughter woke up in the middle of the night crying - she was running a fever of 100 degrees and drenched in sweat, she complained of a headache, a stomachache, and was inconsolable. She vomited 3 times - mostly stomach bile. She was restless, could not sleep, and her body felt like it was on fire. She was also acting confused and not making a lot of sense, but that may have been from the fever. It did eventually go down with Motrin, but she continued to run a fever on and off throughout the day, as well as complained of a headache and overall pain. By the end of the day, 4/15/14, she seems to be back to normal, but this "reaction" did NOT seem to be normal to me.